Ebola Vaccine Is Safe and Effective, According to First Study
Encouraging news! –just in time for dinner
In the first results from tests on an experimental Ebola vaccine, researchers at the National Institute of Allergy and Infectious Diseases (NIAID) report for the first time Wednesday that the shot is safe and that it leads to an immune response among healthy volunteers. The vaccine, developed by the National Institutes of Health and GlaxoSmithKline, was tested in 20 participants in the US at the NIH Clinical Center in Bethesda.
“This tells us that this is kind of a positive signal about moving to the next stage,” says Dr. Anthony Fauci, director of NIAID.
The vaccine is meant to protect uninfected people from Ebola, and, if effective, would be tested next in populations in high-risk areas such as west Africa, where the outbreak is ongoing, to immunize them against the virus. It does not contain live Ebola virus, but does…
View original post 256 more words